National Biomedical Research Act
Latest action · Dec 12, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedDec 11, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
National Biomedical Research Act
This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research.
The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.
Cosponsors 1
Members who signed on, in the order they did. All signed on Dec 11, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-IA | David Loebsack | Original | Dec 11, 2019 |
Actions 3
Everything that happened, newest first.
- Dec 12, 2019Referred to the Subcommittee on Health.
- Dec 11, 2019Introduced in House
- Dec 11, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Aging
- Appropriations
- Budget deficits and national debt
- Cancer
- Child health
- Computers and information technology
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Education programs funding
- Environmental health
- Executive agency funding and structure
- Food and Drug Administration (FDA)
- Genetics
- Government trust funds
- Health
- Health care costs and insurance
- Health information and medical records
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Immunology and vaccination
- Medicaid
- Medical education
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Military medicine
- Minority health
- National Institutes of Health (NIH)
- Neurological disorders
- Nutrition and diet
- Physical fitness and lifestyle
- Poverty and welfare assistance
- Research administration and funding
Text 1
Each version as it was printed, newest first.
- Dec 11, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.